February 8, 2024
Burlington, Ontario – February 7, 2024 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) trading on the Canadian Securities Exchange (“CSE”) under the symbol MKT:DOSE announces the appointment of Angela O’Leary to the Board of Directors. Mark Upsdell, CEO of RDT said ““We are...
January 20, 2024
BURLINGTON, Ontario – January 19, 2024 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that it plans to complete an equity private placement financing (the “Financing”) for up to $7,000,000 of gross proceeds, consisting of up to 41,176,470 units (the...
December 22, 2023
BURLINGTON, Ontario – December 22, 2023 Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is pleased to announce that it has closed on $855,000 in a fourth tranche of its previously announced private placement financing (the “Financing”) bringing the total amount invested to...
December 6, 2023
BURLINGTON, Ontario – December 6, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that further to its press release dated November 14, 2023 announcing a third tranche closing of $500,000, thereby bringing the total amount invested to approximately $2,300,000,...
November 22, 2023
BURLINGTON, Ontario – November 22, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is pleased to announce that it has retained Profinnotiv AG (the “Consultant”) to provide the Company with investor and public relations services in the European market, including brand...
November 14, 2023
BURLINGTON, Ontario – November 14, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is pleased to announce that it has closed on $500,000 in a third tranche of its previously announced private placement financing (the “Financing”) bringing the total amount invested...
October 25, 2023
BURLINGTON, Ontario – October 24, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that further to its press release dated September 22, 2023 announcing a second tranche closing of approximately $300,000, thereby bringing the total amount invested to approximately...
October 19, 2023
As we celebrate Small Business Week, Effie J. Triantafilopoulos, MPP for Oakville North -Burlington, toured the Rapid Dose Therapeutics facility in Burlington on Oct. 12 to discuss their innovative Oral Thin Film (OTF) delivery platform and highlight the company’s recent achievements. “You’ve got seniors who...
October 10, 2023
BURLINGTON, Ontario – October 5, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) announced today that as contemplated in the secured convertible notes (the “Notes”) previously issued on its placement financing (the “Financing”), the Company intends to issue common shares (“Common...
September 22, 2023
Corporate Update BURLINGTON, Ontario – September 22, 2023 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) is pleased to announce that it has closed on $310,000 in a second tranche of its previously announced private placement financing (the “Financing”) bringing the total...